Charles Moran has resigned from the Board of Directors of Duck Creek Technologies, Inc. effective January 19, 2022. Half of Duck Creek's remaining eight directors are independent, and Duck Creek's Nominating and Corporate Governance Committee and Compensation Committee are now compliant with the Nasdaq Global Select Market (“Nasdaq”) continued listing requirements. Duck Creek's Audit Committee remains fully compliant.

On January 19, 2022, Duck Creek informed Nasdaq that it is not in compliance with Nasdaq Rule 5605 which requires a majority of Duck Creek's Board of Directors to be comprised of independent directors, and all members of Board committees to be independent. On January 20, 2022, Duck Creek received a letter from Nasdaq confirming that, pursuant to the cure period provided under Nasdaq Rule 5605(b)(1)(A), Duck Creek has until July 18, 2022 to return to a majority independent Board. Duck Creek has undertaken a search to identify a new independent director and expects to be fully compliant with the Nasdaq continued listing requirements before the expiration of such cure period.